Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing
Open Access
- 23 April 2009
- journal article
- Published by Wiley in Journal of Anatomy
- Vol. 214 (5) , 759-767
- https://doi.org/10.1111/j.1469-7580.2009.01065.x
Abstract
Human mesenchymal stem cells (hMSC) are a heterogeneous cell population, which is reflected in varying morphological and biological properties. Three subpopulations with intrinsic characteristics can be distinguished: small rapidly self‐renewing cells, spindle‐shaped cells and large, flattened cells. Unfortunately, it has neither been possible to morphologically define these distinct cells consistently, nor to relate them to specific surface marker features. Here, the primary hMSC subpopulations of three donors are clearly defined by maximum cell diameter and area. Furthermore, these cells were stained for the putative hMSC surface markers CD105, CD90 as well as CD73, and evaluated by three‐colour flow cytometry and simultaneous multicolour immunocytochemistry. Interestingly, cell cultures with a high rate of triple‐positive hMSC featured a higher content of rapidly self‐renewing cells. On the other hand, a higher fraction of flattened cells correlated with a loss of one or more hMSC surface markers. The expression of CD73 showed the highest heterogeneity. Immunocytochemistry further confirmed that flattened cells mainly lack CD73 expression, whereas rapidly self‐renewing cells were steadily positive for all three hMSC markers. In the literature, hMSC properties are especially conceded to rapidly self‐renewing cells, whereas flattened cells have been suggested to represent early stages of lineage‐specific progenitors. We reveal that among the recently suggested surface markers, CD73 is the most sensitive, as it seems to be down‐regulated in the early stages of differentiation. Our morphological and immunocytochemical characterization of hMSC subpopulations indicates the yield of early multipotent hMSC and thereby provides a quality control approach for hMSC culturing.Keywords
This publication has 45 references indexed in Scilit:
- Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cellsBlood, 2008
- Researching into the cellular shape, volume and elasticity of mesenchymal stem cells, osteoblasts and osteosarcoma cells by atomic force microscopyJournal of Cellular and Molecular Medicine, 2007
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingThe International Journal of Cell Cloning, 2007
- Human mesenchymal stem cells at the single‐cell level: simultaneous seven‐colour immunofluorescenceJournal of Anatomy, 2007
- Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCsBlood, 2007
- Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin systemJournal of Cellular and Molecular Medicine, 2007
- Growing bone and cartilageThe Journal of Bone and Joint Surgery. British volume, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem CellsBiochemical and Biophysical Research Communications, 2001
- The Monoclonal Antibody SH-2, Raised against Human Mesenchymal Stem Cells, Recognizes an Epitope on Endoglin (CD105)Biochemical and Biophysical Research Communications, 1999